ICL Group Ltd. reported its Q4 2025 results on February 18, 2026, revealing a 6% increase in sales to $1.7 billion but a net loss of $73 million; full-year sales rose 5% to $7.15 billion. The company plans to focus on acquiring Bartek Ingredients and divesting non-core assets for better alignment with strategic goals, anticipating adjusted EBITDA of $1.4 to $1.6 billion in 2026.